Literature DB >> 18278445

Antisense RNA of survivin gene inhibits the proliferation of leukemia cells and sensitizes leukemia cell line to taxol-induced apoptosis.

Wenhan Li1, Xiaojuan Wang, Ping Lei, Qing Ye, Huifen Zhu, Yue Zhang, Jinfang Shao, Jing Yang, Guanxin Shen.   

Abstract

The effects of survivin antisense RNA on proliferation of leukemia cell line HL-60 and taxol-induced chemotherapy was explored. A cDNA fragment of survivin obtained by RT-PCR was inserted into a plamid vector named pcDNA3 in the reverse direction. The vector encoding antisense RNA of survivin was confirmed by restriction enzyme digestion and DNA sequencing. The recombinant plasmid was delivered into HL-60 cells by electroporation. Growth curves were plotted based on cell counting. Trypan blue dye exclusion assay and MTT assay were carried out after the cells were incubated with taxol. DNA gel electrophoresis and nuclear staining were performed for cell apoptosis assay. The correct construction of the recombinant plasmid has been identified by restriction enzyme digestion and DNA sequencing. A stable down-regulation has been achieved in HL-60 SVVas cells after G418 selection. Compared to HL-60 cells, the proliferation of HL-60 SVVas cells was significantly inhibited (P<0.05). Cytotoxicity assays indicated that IC(50) of HL-60 SVVas for taxol was relatively lower than controls (P<0.01). Apoptosis assays revealed that taxol-induced apoptosis was detected in HL-60 SVVas cells incubated with 50 ng/ml taxol for 12 h, while in HL-60 cells incubated with 100 ng/ml taxol for 72 h. It was suggested that Survivin antisense RNA could inhibit the proliferation of HL-60 cells and enhance taxol-induced apoptosis in HL-60 cells, which may lay an experimental foundation for further research on gene therapy in leukemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278445     DOI: 10.1007/s11596-008-0101-1

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  15 in total

1.  Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis.

Authors:  Marzia Pennati; Gennaro Colella; Marco Folini; Lorenzo Citti; Maria Grazia Daidone; Nadia Zaffaroni
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 2.  Role of the Survivin gene in pathophysiology.

Authors:  Fengzhi Li; Michael G Brattain
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization.

Authors:  P Giannakakou; D L Sackett; Y K Kang; Z Zhan; J T Buters; T Fojo; M S Poruchynsky
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

4.  A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy.

Authors:  R A Olie; A P Simões-Wüst; B Baumann; S H Leech; D Fabbro; R A Stahel; U Zangemeister-Wittke
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

5.  Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis.

Authors:  S Kamihira; Y Yamada; Y Hirakata; M Tomonaga; K Sugahara; T Hayashi; N Dateki; H Harasawa; K Nakayama
Journal:  Br J Haematol       Date:  2001-07       Impact factor: 6.998

6.  The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression.

Authors:  F Li; D C Altieri
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

Review 7.  [Survivin: anti-apoptosis protein and a prognostic marker for tumor progression and recurrence].

Authors:  B Sela
Journal:  Harefuah       Date:  2002-01

8.  Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation.

Authors:  C Adida; P L Crotty; J McGrath; D Berrebi; J Diebold; D C Altieri
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

Review 9.  The universal character of the tumor-associated antigen survivin.

Authors:  Mads Hald Andersen; Inge Marie Svane; Jürgen C Becker; Per Thor Straten
Journal:  Clin Cancer Res       Date:  2007-10-15       Impact factor: 12.531

10.  A p34(cdc2) survival checkpoint in cancer.

Authors:  Daniel S O'Connor; Nathan R Wall; Andrew C G Porter; Dario C Altieri
Journal:  Cancer Cell       Date:  2002-07       Impact factor: 31.743

View more
  1 in total

1.  Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia.

Authors:  Yock-Ping Chow; Hamidah Alias; Rahman Jamal
Journal:  BMC Cancer       Date:  2017-02-10       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.